Close
Back to ITRM Stock Lookup
Pages: 1 2 3 4 »» Last Page

Iterum Therapeutics Plc (ITRM) – Globe Newswire

Mar 28, 2024 07:00 AM Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
Mar 21, 2024 04:30 PM Iterum Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
Mar 15, 2024 08:00 AM Iterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside Chat
Mar 6, 2024 08:00 AM Iterum Therapeutics Provides Business Update
Dec 4, 2023 08:00 AM Iterum Therapeutics Regains Compliance with Nasdaq Bid Price Rule
Nov 14, 2023 07:00 AM Iterum Therapeutics Reports Third Quarter 2023 Financial Results
Nov 7, 2023 08:30 AM Iterum Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on November 14, 2023
Oct 24, 2023 08:00 AM Iterum Therapeutics Announces Completion of Enrollment in its REASSURE Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections
Oct 12, 2023 09:15 AM Iterum Therapeutics to Present Data at IDWeek 2023
Aug 11, 2023 07:00 AM Iterum Therapeutics Reports Second Quarter 2023 Financial Results
Aug 4, 2023 05:00 PM Iterum Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results on August 11, 2023
Jun 12, 2023 06:23 PM Iterum Therapeutics to Present Data at ASM Microbe 2023
May 12, 2023 07:00 AM Iterum Therapeutics Reports First Quarter 2023 Financial Results
Apr 20, 2023 05:00 PM Iterum Therapeutics Presents Scientific Posters at ECCMID 2023 Highlighting Application of Desirability of Outcomes Ranking (DOOR) to two Registration Trials
Mar 16, 2023 07:00 AM Iterum Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
Mar 9, 2023 05:00 PM Iterum Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023
Jan 11, 2023 06:00 PM Iterum Therapeutics Reports Employment Inducement Grant
Jan 11, 2023 06:00 PM Iterum Therapeutics Reports Employment Inducement Grant
Dec 15, 2022 08:00 AM Iterum Therapeutics announces Issuance of Allowance for a U.S. Patent Covering Oral Sulopenem
Dec 15, 2022 08:00 AM Iterum Therapeutics announces Issuance of Allowance for a U.S. Patent Covering Oral Sulopenem
Nov 10, 2022 07:00 AM Iterum Therapeutics Reports Third Quarter 2022 Financial Results
Nov 10, 2022 07:00 AM Iterum Therapeutics Reports Third Quarter 2022 Financial Results
Nov 3, 2022 08:00 AM Iterum Therapeutics to Provide Business Update and Report Third Quarter 2022 Financial Results on November 10, 2022
Nov 3, 2022 08:00 AM Iterum Therapeutics to Provide Business Update and Report Third Quarter 2022 Financial Results on November 10, 2022
Oct 20, 2022 07:30 AM Iterum Announces First Patient Dosed in REASSURE, a Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections
Oct 20, 2022 07:30 AM Iterum Announces First Patient Dosed in REASSURE, a Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections
Oct 17, 2022 05:19 PM Iterum Therapeutics to Present Data at IDWeek 2022
Oct 17, 2022 05:19 PM Iterum Therapeutics to Present Data at IDWeek 2022
Sep 19, 2022 07:30 AM Iterum Therapeutics announces Issuance of Allowance for a U.S. Patent Covering Oral Sulopenem
Sep 19, 2022 07:30 AM Iterum Therapeutics announces Issuance of Allowance for a U.S. Patent Covering Oral Sulopenem
Sep 7, 2022 09:15 AM Iterum Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Sep 7, 2022 09:15 AM Iterum Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Sep 1, 2022 04:15 PM Iterum Therapeutics Regains Compliance with Nasdaq Bid Price Rule
Sep 1, 2022 04:15 PM Iterum Therapeutics Regains Compliance with Nasdaq Bid Price Rule
Aug 16, 2022 09:00 PM Iterum Therapeutics Announces Date of 1-for-15 Reverse Share Split
Aug 16, 2022 09:00 PM Iterum Therapeutics Announces Date of 1-for-15 Reverse Share Split
Aug 12, 2022 07:00 AM Iterum Therapeutics Reports Second Quarter 2022 Financial Results
Aug 12, 2022 07:00 AM Iterum Therapeutics Reports Second Quarter 2022 Financial Results
Jul 11, 2022 07:30 AM Iterum Therapeutics Announces Special Protocol Assessment (SPA) Agreement With the FDA
Jul 11, 2022 07:30 AM Iterum Therapeutics Announces Special Protocol Assessment (SPA) Agreement With the FDA
Jul 6, 2022 04:30 PM Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jul 6, 2022 04:30 PM Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jun 14, 2022 05:00 PM Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jun 14, 2022 05:00 PM Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 13, 2022 07:00 AM Iterum Therapeutics Reports First Quarter 2022 Financial Results
May 13, 2022 07:00 AM Iterum Therapeutics Reports First Quarter 2022 Financial Results
May 11, 2022 08:00 AM Iterum Therapeutics Provides Regulatory Update
May 11, 2022 08:00 AM Iterum Therapeutics Provides Regulatory Update
Apr 25, 2022 05:06 PM Iterum Therapeutics Presented Data at the 32nd European Congress of Clinical Microbiology and Infectious Diseases
Apr 25, 2022 05:06 PM Iterum Therapeutics Presented Data at the 32nd European Congress of Clinical Microbiology and Infectious Diseases
Pages: 1 2 3 4 »» Last Page

Back to ITRM Stock Lookup